European Psychiatry: Volume 20 -

European Psychiatry

Only show content I have access to (192)

Over 3 years (306)

View selected items
Save to my bookmarks
Export citations
Download PDF (zip)
Save to Kindle
Save to Dropbox
Save to Google Drive
Save content to
To save this undefined to your undefined account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your undefined account. Find out more about saving content to .

To save this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Please be advised that item(s) you selected are not available.
You are about to save
European Psychiatry
ISSN: 0924-9338

EISSN: 1778-3585

URL: /core/journals/european-psychiatry
Your Kindle email address

Please provide your Kindle email.

@free.kindle.com @kindle.com (service fees apply)

By using this service, you agree that you will only keep content for personal use, and will not openly distribute them via Dropbox, Google Drive or other file sharing services

European Psychiatry

Refine listing

Actions for selected content:

Volume 20 - March 2005

Psychotic disorders

S-30. Symposium: New challenges to the dichotomy schizophrenia versus affective disorder — Part I

S-37. Symposium: Pharmacogenetics of antipsychotic treatment: Predicting clinical efficacy and side effects

S-39. Symposium: Early recognition ofpsychoses

S-43. Symposium: German schizophreniaresearch network: Results from clinical follow-up and intervention studies

S-46. Symposium: Neurophysiologicalindicators of vulnerability to schizophrenia — endophenotypes of the disease

S-55. Symposium: Endophenotypes formolecular genetic studies in schizophrenia

S-51. Symposium: Treatment of first episodeschizophrenia

S-60. Symposium: The European Prediction of Psychosis Study (EPOS) — First follow-up results

S-61. Symposium: Overlapping ofscizophrenic and affective spectra

S-65. Symposium: New challenges to the dichotomy schizophrenia versus affective disorder — part II

S-69. Symposium: Imaging genomicsin psychiatric research

SS-01. Section symposium: Genes forschizophrenia: Susceptibility to what? part I: Insights from gene-environment interactions

SS-02. Section symposium: Newdevelopments in functional and structural neuroimaging in schizophrenia

SS-05. Section symposium: Genes forschizophrenia: Susceptibility to what? part II: Insights from neuroimaging

SS-08. Section symposium: Schizophrenia —Nature and narratives

SS-09. Section symposium: Antipsychotics:Effectiveness beyond mere symptom control in schizophrenia patients

SS-15. Section symposium: Cognitiveendophenotypes and pharmacological treatment of schizophrenia

W-09. Workshop: Schizophrenia, thalamusand the cortex: Molecular and functional neuroimaging studies

C-03. Educational course: How to develop a programme against stigma and discrimination because of schizophrenia

C-12. Educational course: Cognitivedysfuction in schizophrenia — Brief clinical assessments and treatment strategies

European Psychiatry

Refine listing

Actions for selected content:

Save Search

Volume 20 - March 2005

Psychotic disorders